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2 
The shikimate pathway is the only known biosynthetic route for de novo synthesis of aromatic 23 
compounds.  It is described as an ancient eukaryotic innovation that has been retained in a 24 
subset of eukaryotes, replaced in plants through the acquisition of the chloroplast, but lost in 25 
many including humans. Herein, we demonstrate that Acanthamoeba castellanii possesses the 26 
shikimate pathway by biochemical and a combination of bioinformatics and molecular 27 
biological methods. The growth of A. castellanii (Neff strain and a recently isolated clinical 28 
specimen, both T4 genotypes) is inhibited by glyphosate [N-(phosphonomethyl) glycine], an 29 
inhibitor of EPSP synthase and the addition of phenylalanine and tryptophan, which are 30 
dependent on the shikimate pathway, rescued A. castellanii from glyphosate indicating that 31 
glyphosate was specific in action.  A. castellanii has a novel complement of shikimate pathway 32 
enzymes including unique gene fusions, two Type I and one Type II DAHP synthases (for 33 
which their likely sensitivities to feedback inhibition by phenylalanine, tyrosine and 34 
tryptophan has been modelled) and a canonical chorismate synthase.  The shikimate pathway 35 
in A. castellanii therefore has a novel molecular arrangement, is required for amino acid 36 
biosynthesis and represents an attractive target for antimicrobials. 37 
 38 
Key words: Acanthamoeba castellanii; shikimate pathway; glyphosate inihibition; novel 39 
molecular arrangement. 40 
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3 
Introduction 46 
Acanthamoeba (species) are facultative parasites that can cause a painful sight-threatening keratitis 47 
or fatal granulomatous encephalitis in humans.  Although many options for the treatment of ocular 48 
Acanthamoeba infections exist, most are essentially disinfectants that have necessarily arduous 49 
regimens with limited efficacy (Marciano-Cabral and Cabral 2003).  Furthermore, eye care 50 
solutions are not currently routinely tested against Acanthamoeba and no single-step contact lens 51 
solution has proven effective at decontaminating lenses from Acanthamoeba. Granulomatous 52 
Amoebic Encephalitis (GAE) is normally associated with immunosuppression and is almost always 53 
fatal as current treatments are generally ineffective (Seijo Martinez et al. 2000). Identification and 54 
exploitation of new antimicrobial targets against Acanthamoeba is therefore desirable. 55 
 The shikimate pathway is a promising target for antimicrobial design since it is the only 56 
known route for de novo synthesis of aromatic compounds.  The shikimate pathway was once 57 
thought to be restricted to prokaryotes, plants (where it is associated with the chloroplast) and fungi. 58 
It has more recently been demonstrated to be present in some chromalveolates including the 59 
medically important apicomplexans Toxoplasma gondii and Plasmodium species, at least some 60 
ciliates and the agriculturally important oomycete, Phytophthora ramorum (Richards et al. 2006; 61 
Roberts et al. 1998). The pathway is now known to be present in phylogenetically divergent extant 62 
eukaryotic taxa and it has been proposed that it was therefore present in their last common ancestor
 
63 
(Campbell et al. 2004; Richards et al. 2006). Some additional weight to this is given by the 64 
molecular arrangement of the enzymes responsible and their phylogeny. Thus with the exception of 65 
phototrophic organisms that have a chloroplast-located, prokaryotic derived pathway, all eukaryotes 66 
examined to date have a characteristic pentafunctional gene fusion (arom) encoding a single 67 
polypeptide responsible for 5 (3-dehydroquinate synthase, 3-dehydroquinate dehydratase, shikimate 68 
5-dehydrogenase, shikimate kinase and EPSP synthase) out of the seven enzyme activities 69 
(Richards et al. 2006).  Phylogenetic studies support that this molecular arrangement is an ancient 70 
eukaryotic innovation that has been inherited in diverse eukaryotes through vertical decent 71 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 
4 
(Richards et al. 2006). In contrast, bacterial shikimate pathway enzymes are encoded on individual 72 
polypeptides (Roberts et al. 1998).  This arrangement is conserved in plants with the exception of 3-73 
dehydroquinate dehydratase and shikimate 5-dehydrogenase, which form a bifunctional protein 74 
(Campbell et al. 2004).  In addition, two non-homologous types of DAHP synthase (designated 75 
class I and II) have been found across a variety of organisms (Butler et al. 1974). Class I proteins 76 
(often occurring as multiple paralogs in a single organism) were originally identified in prokaryotes, 77 
but are also found in many fungi and the chromalveolates, Phytophthora ramorum and 78 
Phytophthora infestans (Coggins et al. 1987; Herrmann and Weaver 1999; Richards et al 2006).  79 
Although class II DAHP synthases were first identified in plants, they are now known to be in 80 
bacteria, fungi and the chromalveolate Toxoplasma gondii (Dyer et al. 1990; Gosset et al. 2001; 81 
Richards et al. 2006; Shumilin et al. 1996). A number of prokaryotes and some fungi including 82 
Neurospora crassa contain both classes of DAHP synthases (Walker et al. 1996).  Class I DAHP 83 
synthases often existing as multiple paralogs and class II DAHP synthases are frequently regulated 84 
by one or more aromatic amino acids (Jensen et al. 2002). 85 
 The shikimate pathway is still relatively rare in sampled eukaryotes and is absent in 86 
mammals that acquire their aromatic compounds from diet.   This makes it an attractive target for 87 
antimicrobial agents (Bentley 1990; Jensen 1996; Roberts et al. 2002).  Herein, we demonstrate that 88 
the shikimate pathway is essential for Acanthamoeba growth in absence of exogenous aromatic 89 
amino acids, describe its molecular organisation and demonstrate its potential as a target for 90 
antimicrobials. 91 
 92 
Results 93 
Glyphosate Restricts Acanthamoeba castellanii Growth in vitro 94 
The effectiveness of glyphosate as an inhibitor of A. castellanii growth was assessed by a modified 95 
version of the alamarBlue microtiter plate assay. A. castellanii trophozoites were grown in defined 96 
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5 
medium lacking aromatic compounds (folate and the aromatic amino acids tyrosine, phenylalanine 97 
and tryptophan). Glyphosate significantly restricted A. castellanii Neff strain and the A. castellanii 98 
clinical strain growth in a dose dependent manner (Fig. 1).  The IC50 for the Neff strain was 99 
determined to be between 17.5µM and 35µM for the Neff strain and 70µM to 140µM for the 100 
clinical strain. Importantly, it did not induce encystment (Fig. 1D). 101 
 102 
Glyphosate is not Toxic to Rabbit Corneal Epithelial Cells 103 
The toxicity of glyphosate to rabbit corneal epithelial (RCE) cells was assessed via the alamarblue 104 
microtiter plate assay. There was no inhibition of the metabolic activity of the RCE by glyphosate at 105 
concentrations (17.5µM to 1130µM), which inhibited the growth of A. castellanii (Fig. 1C). 106 
 107 
Acanthamoeba Relies on the Shikimate Pathway for Aromatic Amino Acids  108 
To confirm that glyphosate was specifically acting on EPSP synthase and thus the shikimate 109 
pathway and to determine which products derived from the shikimate pathway, precursors were 110 
necessary for A. castellanii, PABA and aromatic amino acids were added alone and in combination 111 
to glyphosate treated trophozoites. The addition of tyrosine (up to 0.66mM), phenylalanine (up to 112 
10mM) and tryptophan (up to 1.96mM) separately did not negate the effects of glyphosate (Fig. 113 
2A). However, simultaneous addition of phenylalanine and tryptophan ablated any inhibitory effect 114 
of glyphosate (Fig. 2B).  Tyrosine, in combination with either phenylalanine or tryptophan, and 115 
PABA were neither necessary nor sufficient to ablate glyphosate inhibition (Fig. 2B, C). 116 
Bioinformatic analyses have identified all enzymes necessary for the production of phenylalanine 117 
(Fig. 3), tryptophan and folates from chorismate (Supplementary Material Fig. S1). Enzymes 118 
involved in tyrosine biosynthesis directly from chorismate are not present, but those necessary for 119 
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6 
tyrosine biosynthesis from phenylalanine via phenylalanine-4-hydroxylase are present (Genbank 120 
ELR14932.1). Notably, the enzymes involved in ubiquinone biosynthesis are not found.  121 
 122 
Acanthamoeba have both Type I and II DAHP Synthases  123 
The transcriptome data (Clarke et al. 2013) was interrogated and two type I DAHP synthases 124 
(DAHPI) were identified.(Accession numbers ELR16577.1 and ELR11971.1). Both DAHP 125 
synthases were successfully amplified from A. castellanii Neff strain and clinical specimen cDNAs 126 
(Accession numbers KC471625 and KC471626, respectively, Fig. 4A). 127 
 The Phyre2 program produced models for each enzyme and permitted an examination of the 128 
Phe/Tyr/Trp inhibition site conservation for AcDAHPIa and AcDAHPIb.  A model for the type I 129 
DAHP synthase was generated from both A.castellanii sequences based on the E. coli crystal 130 
structure to which both sequences share very high sequence identity (Fig. 4A). The Phe binding 131 
pocket is formed by 16 residues, of which only 1 differs in the E. coli structure with Ser being 132 
replaced by Gly in the AcDAHPIa, but not AcDAHPIb sequence (Fig. 4A). The predicted position 133 
of Ser allows it to pack against the the Phe substrate with the replacement by Gly in the AcDAHPIa 134 
sequence possibly accommodation of the bulkier hydroxyl group of a Tyr residue (Fig. 4C, D). This 135 
Ser/Gly change may allow for the type I DAHP synthase to be regulated by Tyr or Phe in the 136 
AcDAHPIa and AcDAHPIb sequences, respectively.  137 
 DAHP synthase type II (DAHPII) was found in the A. castellanii transcriptome (Accession 138 
number ELR24167) (Clark et al. 2013).  The putative A. castellanii DAHPII shares a high degree of 139 
similarity to a number of type II DAHP synthases. Modelling of the A. castellanii DAHP type II 140 
(AcDAHPII) synthase was based on  M. tuberculosis DAHP typeII (MtDAHPII), which has been 141 
solved in complex with both Phe and Trp inhibitors (Webby et al. 2010). The MtDAHPII contains a 142 
primary Phe binding site located in the heart of the dimer interface, formed by residues from each 143 
monomer. Of the 10 residues which make up the binding pocket only 2 are conserved with a further 144 
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7 
2 showing close similarity (Fig. 5A), with 2 residues found on the C-WHUPLQDO ȕ-strand which is 145 
predicted to be structurally absent in the AcDAHPII structure (Fig. 4A). Moreover, those residues 146 
responsible for forming a hydrogen bond network in MtDAHPII (Arg171 and Asn175)  are replaced 147 
by Gln and His, respectively (Fig. 5B). The replacement of Ala in MtDAHPII to Phe in AcDAHPII 148 
in the predicted Phe binding site, may also create a steric clashes and would make dimer formation 149 
in the presence of Phe unlikely (Fig. 5C). The secondary Phe binding site within MtDAHPII 150 
involves 9 residues of which Arg23, Arg256 and Glu53 have been shown to be critical in forming a 151 
hydrogen bond netwRUNWRWKHĮ-carboxylate group of the Phe inhibitor, none of these are conserved 152 
in AcDAHPII but are replaced by Thr, Ala and Gln, respectively. This significant change would 153 
make it unlikely that the AcDAHPII enzyme is inhibited by Phe in a manner similar to that seen for 154 
MtDAHPII. In addition to Phe, MtDAHPII is also inhibited by Trp which binds in a site formed by 155 
17 residues of which 6 are identical and 4 are similar in the AcDAHPII enzyme. Modelling suggests 156 
that AcDAHPII would have a similar hydrophobic binding pocket of the same approximate shape. 157 
Interestingly, MtDAHPII is inhibited only by the presence of both Phe/Tyr and Trp at biologically 158 
relevant concentrations. The predicted lack of a conserved Phe/Tyr binding site may imply that 159 
AcDAHPII is inhibited only by Trp and does not require the allosteric binding of Phe or Tyr. 160 
Alternatively Trp does not regulate the enzyme, or an alternative binding site is present which has 161 
so far not been characterised. Further biochemical and structural investigation is required to validate 162 
these models which give only a prediction of the A. castellanii DAHP family. 163 
 164 
Acanthamoeba have a Novel Tetrafunctional Protein with Tetrafunctional Gene Fusion 165 
Comprising 3-dehydroquinate Synthase (DHQS), 5-enolpyruvylshikimate-3-phosphate 166 
Synthase (EPSPS), Shikimate Kinase (SK) and 3-dehydroquinate Dehydratase (DH) 167 
Bioinformatical analysis of the transcriptome data (Clarke et al. 2013) reveals that four out of five 168 
of the AROM enzymes are present in a tetrameric fusion and that the shikimate dehydrogenase is 169 
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8 
missing from the sequence. Accession number ELR24870 is named shikimate kinase but it actually 170 
contains 3-hydroquinate synthase (DHQS), 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), 171 
shikimate kinase (SK) and 3-dehydroquinate dehydratase (DH). This unusual and novel 172 
arrangement was confirmed by PCR from cDNA from both A. castellanii Neff strain and the 173 
clinical strain (KC479580 and KC471623, respectively; Fig. 6). The AROM-like sequence (aromN 174 
±Novel-) is 3927 nucleotides in length, and codes for protein with a predicted molecular weight of 175 
143.3kDa and shares identity and similarity with a number of AROM proteins from other species 176 
(Supplementary Material Fig. S2).  177 
 178 
Acanthamoeba castellanii have a Novel Trifunctional Gene Fusion Comprising Shikimate 179 
Dehydrogenase, Phosphoribosylanthranilate Isomerase and Indole-3-glycerol-phosphate 180 
Synthase!181 
Analysis of the transcriptome data (Clarke et al. 2013) confirmed the existence of a novel 182 
trifunctional gene fusion comprising of indole-3-glycerol-phosphate synthase, 183 
phosphoribosylanthranilate isomerase and shikimate dehydrogenase (Accession number 184 
ELR21144). This fusion was confirmed by PCR in both strains studied (Accession numbers 185 
KC479581 and KC471624, Neff and clinical isolates, respectively; Supplementary Material Fig. 186 
S3).  Modelling of the trimeric fusion proved unreliable due to the absence of a current complex 187 
structure. However, two models could be reliably generated of the bi-functional 2 188 
phosphoribosylanthranilate isomerase:3 indoleglycerolphosphate (RCSB ID. 1pii) and bi-functional 189 
3±dehydroquinate dehydratase/shikimate dehydrogenase (RCSB ID 2o7q). The common fold 190 
shared between the bi-functional complexes and their subsequent superposition permits for an 191 
approximate model of the trimeric fusion to be generated.  192 
 193 
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9 
Acanthamoeba have a Canonical Chorismate Synthase!194 
Based on these sequences primers (chorismate synthase For ¶-GGTGCAGGCGACAAGGCAAC-195 
¶ DQG FKRULVPDWH V\QWKDVH 5(9 ¶-AAGTACTTTTTCTGGAGCTG-¶) were designed and hot 196 
start, which spans both contigs identified. A. castellanii chorismate synthase is present in the 197 
transcriptome (Accession number ELR21143) (Clarke et al. 2013).  PCR (annealing at 58 
o
C) 198 
amplified the gene encoding chorismate synthase from A. castellanii Neff strain cDNA (Accession 199 
number KC471628) and subsequently from the clinical isolate (Accession number KC471627). 200 
AcCS shares identity and similarity with a number of type I chorismate synthases from other 201 
species (Supplementary Material Fig. S4).  202 
 203 
Discussion 204 
Our work has demonstrated that the shikimate pathway has a wider eukaryotic phylogenetic 205 
distribution than previously thought
 
(Campbell et al. 2004; Richards et al. 2006). Thus, the 206 
shikimate pathway would appear to have been present in the last universal common ancestor of 207 
eukaryotes and has been selectively lost in the vast majority of extant eukaryotes sampled to date, 208 
replaced in plants predominantly through the acquisition of the chloroplast and retained by fungi, 209 
and a select few of sampled chromalveolates including some apicomplexans, ciliates and oomycetes
 
210 
(Campbell et al. 2004; Richards et al. 2006).  The current studies now demonstrate the shikimate 211 
pathway in at least one member of the Amoebozoa. This would support the notion that the 212 
shikimate pathway is an ancient eukaryotic trait.  The ability of glyphosate to inhibit the growth of a 213 
laboratory strain of A. castellanii (Neff) and a recently isolated clinical strain demonstrates the 214 
potential utility of targeting this pathway with antimicrobials. 215 
 The shikimate pathway catalyses the sequential conversion of erythrose 4±phosphate and 216 
phosphoenol pyruvate to chorismate in seven steps.  The studies described here fully characterise 217 
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10 
and report the existence of the shikimate pathway in A. castellanii.  The pathway has the potential 218 
to be an antimicrobial target used to limit infection and the genes encoding the enzymes of this 219 
pathway have a novel molecular arrangement.  220 
 The potential for the shikimate pathway to be an antimicrobial target is exemplified by 221 
glyphosate which restricts A. castellanii growth in a dose-dependent manner, albeit in the absence 222 
RIWKHSDWKZD\¶VHQGSURGXFWs (aromatic amino acids, folate and ubiquinone). Interestingly, only a 223 
combination of phenylalanine and tryptophan or all three aromatic amino acids together can rescue 224 
A. castellanii growth from the effects of glyphosate. Bioinformatic analysis reveals that A. 225 
castellanii can create phenylalanine and tryptophan directly from chorismate, whereas the important 226 
enzyme, prephenate dehydrogenase in tyrosine synthesis from chorismate is not present. However, 227 
tyrosine can be synthesised from phenylalanine via the enzyme phenylalanine-4-hydroxylase. A. 228 
castellanii also possess the ability to synthesise folates. However, the addition of folates alone did 229 
not ablate the inhibitory effect of glyphosate. A plausible explanation to the reason that aromatic 230 
amino acids can rescue A. castellanii growth in the absence of folate but the reverse is not possible 231 
may be due to the fact that folates can be recycled through gammaglutamyl hydrolase (EC 232 
3.4.19.9), which has been identified in A. castellanii (ELR19434)
 
(Clarke et al. 2013). In our 233 
experiments, it is likely that A. castellanii are recycling folate, since they are initially maintained in 234 
a rich mycological peptone medium before a step by step passage to a defined minimal medium. 235 
Enzymes involved in ubiquinone biosynthesis have not been found despite extensive 236 
bioinformatical searches. Future studies will be required to determine how A. castellanii acquires 237 
ubiquinone.  238 
 We have for the first time identified two class I DAHP synthases and a class II DAHP 239 
synthase in A. castellanii.  This is similar to the situation in Neurospora crassa where it has both a 240 
tyrosine sensitive and a phenylalanine sensitive class 1 DAHP synthase along with a class II DAHP 241 
synthase that is sensitive to tryptophan (Chaleff et al. 1974).  Modelling of the two A. castellanii 242 
class I DAHP sequences has suggested the apparent conservation of the Phe binding site with the 243 
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11 
replacement of Ser to Gly in the binding site possibly permitting the two A. castellanii class I 244 
DAHP synthases to be regulated by both Phe and Tyr (Fig. 3), although further biochemical studies 245 
are required to validate this.  Unlike bacteria, which contain an AroF, AroG and AroH class I 246 
DAHP synthase, which can be regulated by Tyr, Phe and Trp, respectively, A. castellanii has only 247 
the AroG homologue. The two different AroG sequence, may allow for a Phe or Tyr regulation 248 
mechanism although no clear Trp site can be identified. Further biochemical characterisation will be 249 
required to show that both Tyr and Phe can regulate the shikimate pathway through the two class I 250 
enzymes.  251 
 In addition to the class I DAHP enzymes a second class of DAHP enzyme has been found 252 
which is distinct in architecture form the class I family. This second class has been shown to be 253 
regulated by Phe, Tyr and Trp with either Phe/Tyr being required in the presence of Trp to cause 254 
inhibition. The structure of the M. tuberculosis class II DAHP enzyme (MtDAHPII) has 255 
characterised the architecture of both the Phe/Tyr and Trp binding pockets. Modelling of A. 256 
castellanii homologues suggests it may lack the pre-requisite amino acids, which form the binding 257 
site with an Ala/Phe mutation causing a severe steric clash with the proposed bound Phe. The Trp 258 
binding site appears well conserved within the A. castellanii class II DAHP (AcDAHPII) although 259 
whether this binding requires the cooperative binding of Phe/Tyr as well is as yet undetermined. 260 
The putative modelling has predicted that A. castellanii has 3 DAHP enzymes, (2 class I and 1 class 261 
II), of these the class I enzymes can be regulated by Phe/Tyr and the class II by Trp. Other binding 262 
sites may exist which have not yet been characterised. However, these results show that the 263 
shikimate pathway in A. castellanii could be feedback regulated by 3 different aromatic amino acids 264 
as described in Neurospora crassa
 
(Chaleff et al. 1974). 265 
 The shikimate pathway enzymes have distinct molecular organisations in different groups of 266 
species (Chaleff et al. 1974). Each of the shikimate pathway enzymes is encoded on individual 267 
polypeptides in bacteria (Butler et al. 1974).  Plants have discrete polypeptides with each enzyme 268 
activity with the exception of 3-dehydroquinate dehydratase and shikimate 5-dehydrogenase which 269 
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12 
are fused as separate domains on a single polypeptide (Coggins et al. 1987).  In all eukaryotes 270 
previously examined, 3-dehydroquinate synthase, 3-dehydroquinate dehydratase, shikimate 5-271 
dehydrogenase, shikimate kinase and EPSP synthase are encoded on a single transcript to form a 272 
pentafunctional polypeptide (termed AROM) (Richards et al. 2006).  The current studies now 273 
describe a further novel arrangement as A. castellanii consisting of two previously undescribed gene 274 
fusions. Thus, A. castellanii have a novel tetrafunctional protein comprising 3-dehydroquinate 275 
synthase, 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase, 3-dehydroquinate dehydratase and 276 
shikimate kinase. This fusion has the four enzyme activities ordered in the same sequence as the 277 
first 4 activities of AROM. We have designated this tetrafunctional protein AROMn µQ¶LVQRWRQO\278 
next in the alphabet, but to also denotes this novel arrangement).  The enzyme activity missing from 279 
the AROM-like protein, shikimate dehydrogenase is instead part of a novel trifunctional protein 280 
comprising shikimate dehydrogenase, phosphoribosylanthranilate isomerase and indole-3-glycerol-281 
phosphate synthase. Although a gene fusion comprising shikimate dehydrogenase with these 2 282 
tryptophan biosynthesis enzymes is novel, certain eukaryotes including Phaeodactylum tricornutum 283 
(a diatom), P. ramorum (an oomycete) and Ustilago maydis (a fungus) have a fused 284 
phosphoribosylanthranilate isomerase and indole-3-glycerol-phosphate synthase (Jiroutová et al. 285 
2007).  The functional implications, if any of this fusion is yet to be determined, but its unique 286 
arrangement could prove to be a novel target for therapeutic development. These novel gene fusions 287 
will require phylogenetic analyses to determine their likely evolutionary origins.  288 
 Chorismate synthase is responsible for the final reaction of the shikimate pathway and is 289 
dependent on reduced flavin for its function.  Chorismate synthase is known to have an endogenous 290 
flavin reductase capability in fungi, apicomplexans and ciliates examined to date (Ehammer et al. 291 
2007). However, in plants and bacteria chorismate synthase has been found to lack flavin reductase 292 
ability and is thus dependent on an alternative source. From chorismate a number of aromatic 293 
products are derived, including folate, ubiquinone and aromatic amino acids. All enzymes 294 
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13 
belonging to these pathways have been identified through bioinformatical analysis
 
(Clarke et al. 295 
2013) (Supplementary Material Fig. S1).  296 
 The shikimate pathway has been exploited in plants as a target for herbicides
 
(Bentley, 297 
1990) and proposed as an antimicrobial target in a number of pathogens including bacteria, fungi 298 
and protozoans.  In addition to glyphosate and number of compounds targeting EPSP synthase have 299 
been experimentally tested as antimicrobials
 
(Bentley 1990). Other enzymes in the shikimate 300 
pathway or downstream of the shikimate pathway have been inhibited by substrate analogues. Thus 301 
for example, (6S)-6-fluoroshikimate and (6R)-6-fluoroshikimate through a process of 302 
biotransformation ultimately inhibit 4-aminobenzoic acid synthesis and chorismate synthase 303 
respectively
 
(Bentley 1990). The work described here suggests that the current antimicrobials 304 
designed against the shikimate pathway have potential against A. castellanii and may provide 305 
further motivation to develop new inhibitors of this pathway.  These inhibitors could be used to 306 
improve the treatment of A. castellanii and improve the ability of contact lens solutions to kill this 307 
potential pathogen. It is also likely that the shikimate pathway is also present in other 308 
Acanthamoeba species based on genetic similarities
 
(Henriquez et al. 2008).  309 
 In conclusion we demonstrate that A. castellanii have a novel shikimate pathway with as yet 310 
unique gene fusions.  This pathway is essential for the production of aromatic amino acids and the 311 
survival of A. castellanii and may be exploitable as an antimicrobial agent target. 312 
 313 
Methods 314 
 315 
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14 
Maintenance of Acanthamoeba castellanii trophozoites: Acanthamoeba castellanii (A. 316 
castellanii) (Neff strain) was originally obtained from Keith Vickerman (Glasgow, United 317 
Kingdom).  A. castellanii T4 (Clinical isolate), isolated from a patient with keratitis was obtained 318 
from Antonella Mattana (University of Sassari, Italy) A. castellanii trophozoites were routinely 319 
grown in 2% mycological peptone w/v (Sigma, Poole, United Kingdom) and 0.9% w/v maltose 320 
(Sigma), or M11 media as previously described by Shukla et al., (1990) modified by removal of 321 
aromatic compounds and augmentation of glucose levels to 36% w/v.  Media were supplemented 322 
with 125µg penicillin/ streptomycin (Sigma). They were incubated until confluent at room 323 
temperature, unless otherwise stated, in 75-cm
2
 tissue culture flasks when they were either 324 
subcultured or harvested following mechanically induced detachment. 325 
 Rabbit corneal epithelial cells: Rabbit corneal epithelial (RCE) cells (ECACC No. 326 
ZHUHFXOWXUHGLQ'XOEHFFR¶V0RGLILHG(DJOH¶V0HGLXP'0(0+DP¶V)-12 (1:1) 327 
containing 15mM HEPES and L-glutamine, supplemented with human corneal growth supplement 328 
(HCGS) (Life Technologies Paisley, United Kingdom), 10% heat-inactivated foetal calf serum 329 
(Sigma), 125µg penicillin/ streptomycin and 125µg amphotericin B (Sigma).  RCE cells were 330 
incubated at 37 
o
C, 5% CO2 in 75-cm
2
 tissue culture flasks until 90-95% confluent, then harvested 331 
or sub-cultured by using TrypLE
TM
 Express enzyme cell detaching medium (Life Technologies).   332 
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 A. castellanii trophozoite growth inhibition assays: A. castellanii trophozoites were 333 
routinely cultured as described above. Confluent flasks were subcultured by mechanical detachment 334 
to increasing concentrations of modified M11 media (50%, 80%, 100%), supplemented with 2% 335 
mycological peptone and 0.9% maltose and with 125µg penicillin/ streptomycin and 125µg 336 
amphotericin B (Sigma, Poole, United Kingdom). The effectiveness of N-(phosphonomethyl) 337 
glycine (glyphosate) as an inhibitor of A. castellanii trophozoites was determined by a modified 338 
version of the colorimetric microtiter plate assay described by McBride et al., (2005).  A. castellanii 339 
cultured in 100% modified M11 media were seeded in triplicate at a concentration of either 4 x 340 
10
5
/ml (Neff Strain) or 1 x 10
6
 (Clinical isolate) in a 96 well tissue culture plate (TPP, Switzerland).  341 
Glyphosate (Sigma) was dissolved in modifieG0PHGLDDQGȝOZDVDGGHGWRHDFKZHOOLQ342 
VHULDOGLOXWLRQVIURP0WR0&RQWUROZHOOVZHUHVXSSOHPHQWHGZLWKȝORIPRGLILHG343 
M11 medium. Where appropriate, aromatic amino acids and/or para-aminobenzoic acid (PABA) 344 
were added separately at different concentrations as stated to determine if such treatment could 345 
ablate the effects of glyphosate. The assay was then incubated for 48 hours at room temperature and 346 
ȝORI$ODPDU%OXHUHDJHQW%LRVRXUFH(XURSHZDVDGGHGWRHDFKZHOODQGIXUWKHULQFXbated at 347 
room temperature, in the dark, for 24 hours.  Absorbances were then read on spectromax (Molecular 348 
Devices) at OD570 and OD600. 349 
 The percentage inhibition of AlamarBlue
TM
 was calculated by the following formula: 350 
^>İoxȜ2) $Ȝ1)] ± >İoxȜ1) $Ȝ2)] >İoxȜ2) (A oȜ1)] ± >İoxȜ1) (A oȜ2) ]} x 100 351 
:KHUH İoxȜ1 LV  PRODU H[WLQFWLRQ FRHIILFLHQW RI R[LGLVHG $ODPDU%OXH DW QP İoxȜ2 is 352 
117,216 (molar extinction coefficient of oxidised AlamarBlue at 600nm); A
 Ȝ1 is the absorbance of 353 
the treated wells at 570nm; A
 Ȝ2 is the absorbance of the treated wells at 600nm; AoȜ1 is the 354 
absorbance of the untreated control wells at 570nm; A
oȜ2 is the absorbance of the untreated control 355 
wells at 600nm.  These absorbance values were subtracted from 100 to give percentage of 356 
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16 
AlamarBlue
TM
 reduction in comparison to untreated controls.  The results were expressed as a mean 357 
for each triplicate ± the standard error (SE) and student T-test analyses were performed. 358 
 Assessment of inhibitor-induced encystment: A. castellanii were cultured, harvested and 359 
seeded as described previously with glyphosate (Sigma) dissolved in modified M11 media and 360 
incubated for 72 hrs at room temperature.  Sodium dodecyl sulphate (SDS), which causes 361 
immediate lysis of A. castellanii trophozoites while mature cysts remain intact, was then used to 362 
assess if the presence of glyphosate had caused A. castellanii to form cysts.  The medium was 363 
carefully removed and replaced with 100µl of 5% SDS then cells were counted manually on a 364 
haemocytometer.  The effect of 5% SDS was also assessed on cyst controls.  In brief 4 x 10
5
/ml
 
A. 365 
castellanii were resuspended in encystment medium (20 mM Tris-HCl ?pH 8.8?, 100 mM KCl, 8 366 
mM MgSO4, 0.4 mM CaCl2, 1 mM NaHCO3)
 
(Campbell et al. 2008) and incubated at room 367 
temperature until cysts had formed.  Cells were then resuspended in 5% SDS and counted manually 368 
on a haemocytometer.  369 
 Susceptibility of rabbit corneal epithelial (RCE) cells to glyphosate: RCE were cultured 370 
and harvested as described. The effect of glyphosate was determined as described by McBride et al. 371 
(2007).  Cells were seeded in tripOLFDWHDWFHOOVSHUZHOOLQȝORI5&(PHGLXPLQDZHOO372 
tissue culture plate (TPP, Switzerland) and allowed to adhere for 3 hours at 37 
o
C, 5% CO2.  373 
Glyphosate (Sigma) was dissolved in 10ml of RCE medium DQGȝOZDVDGGHGWRHDFKZHOOWR374 
give the final concentrations from 1130µM to 17.5µM.  Control wells were supplemented with 50µl 375 
of RCE medium and plates were incubated for 96 hours at 37
o
C, 5% CO2.  10µl of alamarBlue 376 
reagent was added to wells 6 hours prior to the end of the incubation.  Absorbance was then read on 377 
spectromax (Molecular Devices) at OD570 and OD600 and the percentage inhibition of alamarBlue 378 
reduction was calculated as previously described. 379 
 RNA extraction: A. castellanii were cultured and harvested as normal from modified M11 380 
medium.  Cells were collected by a 5 minute centrifugation at 21000g at 4 
o
C and the pellet was 381 
then suspended in 1.0ml of Trizol® reagent (Life Technologies).  Total RNA was isolated using a 382 
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17 
method based on a single-step acid guanidinium thiocyanate-phenol-chloroform protocol described 383 
by Chomczynski & Sacchi (1987). The concentration was determined by measuring absorbance at 384 
260 nm on a spectrophotometer (GeneQuant pro, Amersham Biosciences, and United Kingdom).  385 
Extracted RNA was then stored at -80 
o
C until required for cDNA synthesis and the integrity of the 386 
RNA was assessed via PCR and or gel electrophoresis on a 2% agarose gel. 387 
 A. castellanii genomic DNA extraction: Genomic DNA (gDNA) was obtained by a 388 
modification of the method of Johnson et al. (1986).  In brief, 10
7
 cells were collected by 10-min 389 
centrifugation at 7000g and 4 
o
C.  The pellet was resuspended in 10ml of 0.2M NaCl/10mM 390 
EDTA/10mM Tris-+&OS+6'6ȝJPO3URWHLQDVH.6LJPD3RROH8QLWHG391 
Kingdom), and incubated 3 hours at 50 
o
C with gentle agitation.  10ml of 392 
phenol/chloroform/isoamyl alcohol (50:48:2) was added before centrifugation for 10 minutes at 393 
3000g and 4 
o
C.  The supernatant was removed and this was repeated until the interface was clear.  394 
The DNA solution was extracted with 10ml of chloroform and centrifugation for 10 minutes at 395 
3000g at 4 
o
C beIRUHWKHDGGLWLRQRIȝJPORI51DVH$DQGDIXUWKHULQFXEDWLRQDW oC for 15 396 
minutes.  DNA was precipitated with 10M ammonium acetate and 100% ethanol at -20 
o
C for 1hr 397 
followed by a 10 minute centrifugation at 10,000g and 4 
o
C.  The pellet was resuspended in 0.5 ml 398 
of TE buffer (10mM Tris-HCL, 1mM EDTA, pH 8.0) and the concentration determined by 399 
measuring absorbance at 260 nm on a spectrophotometer (GeneQuant pro, Amersham Biosciences, 400 
United Kingdom).  The integrity of the DNA was assessed via gel electrophoresis on a 0.8% 401 
agarose gel.  All samples were stored at 4 
o
C until required.        402 
 Complementary DNA (cDNA) synthesis and Polymerase chain reaction (PCR): 403 
Complementary DNA (cDNA) was synthesised from A. castellanii total RNA, using AffinityScript 404 
as per manufacturer instructions (Stratagene, Cambridge, UK).  All samples were incubated 55 
o
C 405 
for 60 minutes and 70 
o
C for 15 minutes with the exception of random primers, which were pre 406 
incubated at 25 
o
C for 10 minutes.  Synthesised cDNA was then stored at -20
o
C until required.  407 
Oligonucleotides were designed using MacVector? (Oxford, Biomolecular, UK) and synthesized 408 
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18 
commercially by Life Technologies Ltd. (Paisley, UK).  All standard PCR amplification reactions 409 
ZHUHSHUIRUPHGLQȝOUHDFWLRQV(DFKUHDFWLRQFRQWDLQHGȝO;+LJK)LGHOLW\3&5%XIIHUȝO410 
10 P0G173PL[WXUHȝO mM MgSO4, 25 pmol forward and reverse oligonucleotide primers, 411 
ȝOPROHFXlar H22DQGȝORIA. castellanii cDNA or gDNA.  The samples were then incubated at 412 
94 
o
C IRUPLQXWHEHIRUHWKHDGGLWLRQRIȝOPlatinum® Taq High Fidelity (Life Technologies).  413 
SPRO IRUZDUG DQG UHYHUVH ROLJRQXFOHRWLGH SULPHUV ȝO PROHFXODU +2O (Life Technologies), 414 
ȝORIA. castellanii cDNA or gDNA.  The reactions were performed with initial denaturing at 95oC 415 
for 3-5 minutes followed by 35 or 40 cycles of denaturing at 95 
o
C for 30 seconds, annealing at 52 416 
o
C-64 
o
C for 45 seconds and extension at 72 
o
C for 1-2 minutes.  These reactions were then 417 
completed with a final extension at 72 
o
C for 10 minutes.  PCR products were visualised in a 0.8 - 418 
2% agarose gel on a transilluminator following ethidium bromide staining. 419 
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 Cloning and sequencing of PCR products: PCR-amplified DNA fragments were isolated 420 
from ethidium bromide stained agarose gels via MinElute Gel Extraction Kit (Qiagen, Crawley, 421 
United Kingdom).  The purified PCR amplified products were ligated into the pDRIVE vector using 422 
the Qiagen PCR &ORQLQJ.LW4LDJHQDFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV Competent 423 
'+ĮZHUHWUDQVIRUPHGZLWK5µl of the ligation reaction using the heat shock method (Cohen et al. 424 
1972). Transformed cells were then spread evenly onto LB agar (Sigma, Poole, United Kingdom), 425 
which had been previously coated with 100µg/ml ampicillin, 500µM/ml IPTG and 50µg/ml X-gal 426 
(Sigma, Poole, United Kingdom) and incubated overnight at 37 
o
C. Successful transformants were 427 
screened by blue/white screening and plasmid purification using the QIAprep Spin Miniprep Kit 428 
4LDJHQDFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV Restriction enzyme digest with EcoR1 429 
Digested fragments were assessed via agarose gel electrophoresis.  Automated sequencing of PCR 430 
amplified products was achieved using the M13 forward and reverse primers and performed 431 
commercially by Geneservice Ltd., Cambridge, UK or GATC in accordance with company 432 
guidelines.  Sequences were then assembled using Sequencher
TM
 4.0 (GeneCodes, USA).  433 
 Modelling: Modelling of the A. castellanii shikimate pathway proteins was done using the 434 
Phyre2 server (Kelley and Sternberg 2009)
  
and proposed ligand binding sites detected using the 435 
3DLigand server (Wass et al. 2010). 436 
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Figure Legends 
Figure 1. Glyphosate restricts A. castellanii growth at concentrations which are not toxic to 
mammalian cells.  The percentage of alamarBlue reduction was determined for A. castellanii Neff 
strain (A), Clinical strain (B) and RCE (C) by comparing test cultures to those of untreated controls. .  
Glyphosate significantly inhibited growth of the Neff strain, in a dose dependent manner from 17.5µM 
or above (p<0.05) (A). The IC50 is between 17.5µM and 35µM.  Glyphosate significantly inhibited 
growth of a Clinical isolate, from 17.5µM or above (p<0.05) (B).  Glyphosate did not inhibit RCE 
growth (C). A. castellanii inhibited by glyphosate was washed in 5% SDS to determine cyst formation 
(D).   2.52 x10
5
/ml cysts were found in the encystment media (C2).  8.52x10
3
/ml cysts were counted 
in the untreated controls (C3). Glyphosate does not induce cyst formation. There is a, non-dose 
dependent, increase in the number of cysts in the presence of glyphosate to that of untreated 
controls.  In the presence of glyphosate (280µM) 9.17x10
3
/ml to (70µM) 1.25x10
4
/ ml cysts were 
counted.  The results are expressed as means for triplicate cultures ± SE.  
Figure 2.  Rescue assays were performed to determine specificity of glyphosate to EPSP synthase of 
the shikimate pathway. Rescue was determined by measuring the percentage alamarBlue reduction 
of test cultures compared to those of untreated controls. The addition of single aromatic amino acids 
(Phe, Trp and Tyr) did not ablate the effects of glyphosate (A).  However, by adding either 
phenylalanine and tryptophan or all three amino acids together the effect of glyphosate is significantly 
diminished (p<0.0001 ***) (B).  The presence of exogenous PABA did not rescue glyphosate inhibition 
of trophozoites (C).  
Figure 3.  Diagram of predicted phenylalanine and tyrosine biosynthesis in A. castellanii species. 
Enzymes highlighted in bold have been identified are present in Genbank. Pathways in grey are not 
present. (Chorismate mutase ELR23397, prephenate dehydratase ELR22681, aminotransferase 
ELR13846, phenylalanine-4-hydroxylase ELR14932, tyrosine aminotransferase ELR16760) 
Figure 4. (A) Multiple sequence alignment of the two class I A.castellanii DAHP synthase sequences 
(AcDAHPIa, AcDAHPIb) and the E. coli DHAP synthase (EcDAHPI). Those residues conserved and 
similar are highlighted by red and blue boxes, respectively. Those residues involved in binding the 
Phe inhibitor are labelled by and F above the alignment. (B) Superposition of the EcDAHPI structure 
(yellow) and AcDAHPIa model structure (Magenta). Those residues which form the Phe binding site 
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are shown in stick format and coloured yellow, red, and blue for carbon, oxygen and nitrogen, 
respectively. (C) Surface view of the Phe binding site from EcDAHPI. (D) Surface view of the 
EcDAHPI structure with the Ser/Gly mutation as seen in the AcDAHPIb sequence which produces an 
increase in space for the bound Tyr residue shown in stick format.  
Figure 5. (A) Multiple sequence alignment of the AcDAHPII and MtDAHPII enzymes with those 
residues conserved and similar highlighted by red and blue boxes, respectively. Those residues 
involved in binding an amino acid inhibitor are shown by the label F1 (Primary Phe binding site), F2 
(Secondary Phe binding site) and W (Trp binding site). The primary Phe binding site (B) and Trp 
binding site (C) in MtDAHPIIwith the AcDAHPIImodel structure superposed. The MtDAHPII structure 
is shown in yellow and AcDAHPII magenta. Those residues which have been shown to play a role in 
binding are shown in stick format and coloured Yellow (MtDH2) or Magenta (AcDAHPII) for carbon, 
red for oxygen and blue for nitrogen. The Lys residue which has been proposed to stabLOLVH WKHĮ-
carboxylate group of the Trp inhibitor in MtDAHPII is highlighted by a star (C).  
Figure 6. Arrangement of the shikimate pathway enzymes.  In Bacteria and plants DAHP synthase 
(red), 3-dehydroquinate synthase (orange), 5-enolpyruvylshikimate-3-phosphate synthase (purple), 
shikimate kinase (blue), 3-dehydroquinate dehydratase (yellow), shikimate 5-dehydrogenase (green) 
and chorismate synthase (pink) are encoded on individual polypeptides. In plants, 3-dehydroquinate 
dehydratase and shikimate 5-dehydrogenase are found on separate domains of the same 
polypeptide. Plant enzymes have n-terminal transit sequences that target the enzymes to the 
chloroplast. In fungi, alveolates and oomycetes, 3-dehydroquinate synthase, 3-dehydroquinate 
dehydratase, shikimate 5-dehydrogenase, shikimate kinase and EPSP synthase are encoded on a 
single transcript to form a pentafunctional polypeptide (AROM). Two evolutionary unrelated forms of 
DAHP synthase have been found and designated DAHP synthase I and DAHP synthase II.  Bacteria 
such as E. coli have 3 isoenzymes of DAHP synthase I, but plants such as Arabidopsis thaliana and 
the apicomplexan T. gondii have a single DAHP synthase II. Certain fungi including N. crassa have 2 
isoenzymes of DAHP synthase I and a DAHP synthase II.    In A. castellanii, 3-dehydroquinate 
synthase, 3-dehydroquinate dehydratase, shikimate 5-dehydrogenase, shikimate kinase and EPSP 
synthase are part of a tetra-functional polypeptide (ARON).  DAHP synthase and chorismate synthase 
are found as individual polypeptides. A. castellanii, has 2 isoenzymes of DAHP synthase I and a 
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DAHP synthase II.  Shikimate 5-dehydrogenase is found fused to PRAI-IGPS, an arrangement that is 
not found in any other organism to date.  
 
Supplementary Figures 
Figure S1. Enzymes involved in the folate and tryptophan pathways are present in the A. castellanii 
transcriptome
26
 
Figure S2. Multiple alignment of AROMn with other known AROM sequences from fungal species  
Figure S3. Multiple alignment of A.castellanii IGPS-SD with other fungal species. The tri-protein 
fusion of IGPS-SD in Acanthamoeba is novel in nature 
Figure S4. Multiple alignment of A. castellanii chorismate synthase with other fungal species 
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